维普中文期刊产品整合服务
30篇 您的检索式:作者名="Dager WE"
    题名 作者 年代 出处 被引量
1Antimicrobial dosing concepls and recommendations for critically ill adult patients receiving continuous renal replacement therapy or intermittent hemodialysis 显示文摘HEINTA BH MATZKE GR DAGER WE 2009Pharmacotherapy2009,29,5:1
2Drug-induced thrombocytopenia in critically ill patients显示文摘Priziola JL Smythe MA Dager WE 2010Crit Care Med2010,38,6:1
3Treatment of heparin-induced thrombocytopenia显示文摘Dager WE White RH 2002Ann Pharmacother2002,36,3:1
4Argatroban for heparin-induced thrombocytopenia in hepato-renal failure and CVVHD显示文摘Dager WE White RH 2003Ann Pharmacother2003,37,9:1
5Dabigatran effects on the international normalized ratio, activated partial thromboplastin time, thrombin time, and fibrinogen: a muhicenter, in vitro study 显示文摘Dager WE Gosselin RC Kitchen S 2012AnnPharmacother2012,46,12:1
6Antimicrobial dosing concepts and recommendations for critically ill adult patients receiving continuous renal replacement therapy or intermittent hemodialysis显示文摘Heintz BH Matzke GR Dager WE 2009Pharmacotherapy2009,29,5:1
7Drug-induced thrombocytopenia in critically ill patients显示文摘Priziola JL Smythe MA Dager WE 2010Crit Care Med2010,38,:1
8Using prothrombin complex concentrates to rapidly reverse oral anticoagulant effects显示文摘Dager WE 2011Ann Pharma cother2011,45,78:1
9Antimicrobial Dosing Concepts and Recommendations for Critically Ill Adult Patients Receiving Continuous Renal Replacement Therapy or Intermittent Hemodialysis 显示文摘Heintz BH Matzke GR Dager WE 2009Pharmacotherapy2009,29,5:1
10Reversing dabigatran in life-threatening bleeding occurring during cardiac ablation with factor eight inhibitor bypassing activity 显示文摘Dager WE Gosselin RE Roberts AJ 2013Crit Care Med2013,41,5:1
11Use of lepirudin in patients with heparin-induced thromb-ocytopenia and renal failure requiring hemodialysis显示文摘Dager WE White RH 2001Ann Pharmacother2001,35,:1
12Antimierobial dosing concepts and recommendations for critically ill adult patients receiving continuous renal replacement therapy or intermittent hemodialysis显示文摘Heintz BH Matzke GR Dager WE 2009Pharmacotherapy2009,29,5:1
13Lepirudin in heparin-induced thrombocytopenia and extracorporeal membranous oxygenation显示文摘 Gosselin RC Yoshikawa R 2004Ann Pharmacother2004,38,4:1
14Lepirudin in heparin-induced thrombocytopenia and extracorporeal membranous oxygenation显示文摘Dager WE Gosselin RC Yoshikawa R 0,,04:1
15Systemic anticoagulation consideration inchronic kidney disease 显示文摘Dager WE Kiser TH 2010Adv Chronic Kidney Dis2010,17,:1
16Antimicrobial dosing concepts and recommendations for critically ill adult patients receiving continuous renal replacement therapy or intermittent hemodialysis 显示文摘Heintz BH Matzke GR Dager WE 2009Pharmacotherapy2009,29,5:1
17Dabigatran effects on the international normalized ratio, activated partial thromboplastin time, thrombin time, and fibrinogen: a multicenter, in vitro study显示文摘Dager WE Gosselin RC Kitchen S 2012Ann Pharmacother2012,46,12:1
18Systemic anticoagulant proph-ylaxis for central catheter - associated venous thrombosis incancer patients 显示文摘Chan A Iannucci A?Dager WE 2007Ann Pharmacother2007,41,4:1
19Implementing anticoagulation management by pharmacists in the inpatient setting显示文摘Dager WE Gulseth MP 2007Am J Health-Syst Phann2007,64,10:1
20Implementing anticoagulation management by pharmacists in the inpatient setting显示文摘Dager WE Gulseth MP 2007Am J Health Syst Pharm2007,64,10:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费